Lifestyle

Psomagen, Inc. Cuts Costs and Boosts Profit Margins… Turns Operating Profit Positive for the First Time in the First Three Quarters

Cumulative Revenue of 36.7 Billion Won and Operating Profit of 420 Million Won Gross Profit Margin Rises by 2.2 Percentage Points… Processing Capacity Expanded Through AI Automation

KIM JI-WAN
2026-11-16 10:40:03
[Edaily Reporter KIM JI-WAN ] Psomagen, Inc.(950200)has returned to profitability in cumulative operating profit for the third quarter of this year by prioritizing the automation of its analysis processes and cost reduction. The company improved its profit structure by increasing its gross profit margin while reducing selling, general, and administrative expenses.

(Source: Psomagen, Inc.)

According to Psomagen, Inc. on the 16th, cumulative revenue from January to September this year totaled $25.06 million (approximately 36.7 billion won), and operating profit stood at $289,000 (approximately 420 million won). This marks a turnaround from an operating loss of $63,000 during the same period last year. Cumulative net income also turned positive at $1.41 million (approximately 2.06 billion won), compared to a net loss of $2.71 million in the same period last year.

The improvement in profitability was driven by both profit margins and cost reductions. The cumulative gross profit margin rose by 2.2 percentage points, from 22.2% last year to 24.4% this year. Looking at the third quarter alone, it stood at 26.3%, up 2.4 percentage points from the same period last year. Cumulative selling, general, and administrative expenses totaled $5.83 million (approximately 8.53 billion won), a 6.5% decrease from last year’s $6.24 million.

The company explained that the automation of analytical processes using artificial intelligence (AI) has improved cost efficiency. By establishing a system capable of processing two to three times the previous volume without hiring additional staff, the company has reduced the burden of rising labor costs.

The company is also expanding its business base. Psomagen, Inc. has built a track record in the next-generation sequencing (NGS) field by conducting research projects with U.S. government agencies and the Michael J. Fox Foundation (MJFF), among others. It has also adopted Ultima Genomics’ sequencing platform, the “UG100,” to meet large-scale analysis demands.

Last month, the company secured an additional $3.72 million contract for single-cell analysis from CZ Biohub, an affiliate of the Chan Zuckerberg Initiative (CZI). This project is part of the “Billion Cell Project,” which aims to build a dataset of 1 billion cells for use in biological AI research.

The company also worked to stabilize its financial structure. This year, it sold a portion of its stake in KinHealth, a former subsidiary, and used the proceeds from the share premium to cover accumulated losses. The company expects to achieve an annual profit this year by continuing to secure new orders and improve cost efficiency.

Psomagen, Inc. officials stated, “Through consistent collaboration with global institutions, we are securing additional orders, and our performance and profitability are remaining stable.” The spokesperson added, “In addition to this year’s turnaround, sanctions against Chinese genomic analysis companies are expected to intensify starting next year under the National Defense Authorization Act (which includes the Biosecurity Act). Psomagen, Inc. intends to seize this opportunity to grow into a ‘top-tier’ company in the North American market by securing new clients and expanding orders from existing ones.”

Economy

Corporation

IT·Science

Economy

LGELECTRONICS Enhances Safety and Quality of Humanoid Robots…Aiming to Secure Reliability Early On

LGELECTRONICS is partnering with the Korea Robot Industry Promotion Agency to enhance the safety and quality competitiveness of humanoid robots. Ahead of the unveiling of a bipedal robot in the first …
2026-11-16 10:09:25

Corporation

Psomagen, Inc. Cuts Costs and Boosts Profit Margins… Turns Operating Profit Positive for the First Time in the First Three Quarters

Psomagen, Inc.(950200)has returned to profitability in cumulative operating profit for the third quarter of this year by prioritizing the automation of its analysis processes and cost reduction. The c…
2026-11-16 10:40:03

IT·Science

“It even finds posts you saw a long time ago”… Naver Conducts First Trial of ‘Agent AI Cafe’

Naver (NAVER(035420)) has launched a pilot program for its “Agent AI,” which uses artificial intelligence (AI) to identify and organize members’ experiences and know-how accumulated in Cafe posts and …
2026-11-16 10:48:49